Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-02-25
    E.g., 2018-02-25

Articles

Pages

79088 items
12:38 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

Sanofi exercises option under Nanobody deal with Ablynx

Sanofi (Euronext:SAN; NYSE:SNY) exercised an option under a July 2017 deal with Ablynx N.V. (Euronext:ABLX; NASDAQ:ABLX) to receive exclusive global rights to develop and commercialize two multi-specific Nanobodies to treat immune mediated inflammatory diseases. Nanobodies...
12:37 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

J&J execs launch Centyrins newco Aro

Two former Johnson & Johnson (NYSE:JNJ) executives have co-founded Aro Biotherapeutics Co. (Philadelphia, Pa.) to develop Centyrins for extra-hepatic, receptor-mediated delivery of oligonucleotides and other payloads. Aro President and CEO Susan Dillon was previously global...
12:37 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

Everest gets rights to Tetraphase antibiotic

Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) granted C-Bridge-backed Everest Medicines Ltd. (Boston, Mass.) exclusive rights to develop and commercialize eravacycline (TP-434) in China, Taiwan, Hong Kong, Macau, South Korea and Singapore. Tetraphase will receive $7 million up front...
12:36 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

Incyte and Hengrui end PD-1 mAb deal

Incyte Corp. (NASDAQ:INCY) said in an SEC document filed Feb. 15 that it and Jiangsu Hengrui Medicine Co. Ltd. (Shanghai:3600276) agreed to terminate a deal for SHR-1210 (INCSHR1210), an anti-PD-1 mAb. In 2015, Hengrui granted Incyte...
12:36 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

Organ-on-Chip company Emulate reveals new deals

Emulate Inc. (Cambridge, Mass.) announced partnerships with Roche (SIX:ROG; OTCQX:RHHBY) and Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) on Feb. 20, as well as an initiative with Cedars-Sinai Medical Center (Los Angeles, Calif.). The company's Organs-on-Chips are living,...
12:36 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

Arix, Fosun in China-focused deal

Life sciences investment firm Arix Bioscience plc (LSE:ARIX) partnered with Fosun International Ltd. (HKSE:656) to invest in and build newcos focused on the China market. The deal will give Arix access to investment opportunities in China,...
12:33 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

Oncologie gains rights to Mologen's lefitolimod

Mologen AG (Xetra:MGN) granted Oncologie Inc. (Boston, Mass.) exclusive, global co-development rights and rights to develop, manufacture and commercialize lefitolimod (MGN1703) in China, Hong Kong, Macao, Taiwan and Singapore. Mologen said the co-development portion of...
12:27 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Other News

FDA to hold public workshop on patient experience data guidance

FDA said it will hold a public workshop on March 19 to discuss development of patient-focused drug development guidance as required by the 21st Century Cures Act. The agency is seeking input from multiple stakeholders,...
12:27 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Other News

Cellectis granted U.S. patents for CRISPR T cell therapies

The U.S. Patent Office granted Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) two patents covering the use of RNA-guided endonucleases to develop T cell immunotherapies. Both patents claim methods of editing T cells using transient expression of CRISPR/nuclease components....
12:26 PM, Feb 23, 2018  |  BC Week In Review | Company News  |  Deals

Gilead picks Sangamo's ZFN gene editing for cell therapies

Sangamo Therapeutics Inc. (NASDAQ:SGMO) partnered with the Kite Pharma Inc. subsidiary of Gilead Sciences Inc. (NASDAQ:GILD) to use Sangamo's zinc finger nuclease (ZFN) and adeno-associated virus (AAV) technology to develop next-generation autologous and allogeneic cell...

Pages